Literature DB >> 11328857

Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.

D Waltregny1, I Leav, S Signoretti, P Soung, D Lin, F Merk, J Y Adams, N Bhattacharya, N Cirenei, M Loda.   

Abstract

Androgens control both growth and differentiation of the normal prostate gland. However, the mechanisms by which androgens act upon the cell cycle machinery to regulate these two fundamental processes are largely unknown. The cyclin-dependent kinase (cdk) inhibitor p27 is a negative cell cycle regulator involved in differentiation-associated growth arrest. Here, we investigate the role and regulation of p27 in the testosterone proprionate (TP)-stimulated regeneration of the ventral prostate (VP) of castrated rats. Continuous TP administration to castrated rats triggered epithelial cell proliferation, which peaked at 72 h, and then declined despite further treatment. Castration-induced atrophy of the VP was associated with a significant increase in p27 expression as compared with the VP of intact animals. Twelve hours after the initiation of androgen treatment, total p27 levels as well as its fraction bound to cdk2, its main target, significantly dropped in the VP of castrated rats. Thereafter, concomitantly to the induction of epithelial cell proliferation, the glandular morphology of VP was progressively restored at 48-96 h of TP treatment. During this period of the regenerative process, whereas both proliferating basal and secretory epithelial cells did not express p27, the protein was selectively up-regulated in the nonproliferating secretory epithelial compartment. This up-regulation of p27 expression was coincident with an increase in its association with, and presumably inhibition of, cdk2. At each time point of TP treatment, p27 abundance in the VP was inversely correlated with the level of its proteasome-dependent degradation activity measured in vitro in VP lysates, whereas only slight changes in the amount of p27 transcripts were detected. In addition, the antiandrogen flutamide blocked maximal TP-induced p27 degradation completely. Finally, the expression of skp2, the ubiquitin ligase that targets p27 for degradation, was seen to increase with androgen administration, preceding maximal proliferation and concomitantly to augmented p27 degradation activity. Taken together, our data indicate that androgens mediate both proliferation and differentiation signals in normal prostate epithelial cells in vivo, through regulation of p27.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328857     DOI: 10.1210/mend.15.5.0640

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  24 in total

1.  S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells.

Authors:  Lu Ding; Rong Li; Rongxin Sun; Yang Zhou; Yubo Zhou; Xiaoping Han; Yong Cui; Wu Wang; Qing Lv; Jingping Bai
Journal:  Cell Cycle       Date:  2017-08-03       Impact factor: 4.534

2.  Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.

Authors:  Xin Yuan; Tong Li; Hongyun Wang; Tao Zhang; Moumita Barua; Robert A Borgesi; Glenn J Bubley; Michael L Lu; Steven P Balk
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  A patent review of the ubiquitin ligase system: 2015-2018.

Authors:  Xin Li; Ekinci Elmira; Sagar Rohondia; Jicang Wang; Jinbao Liu; Q Ping Dou
Journal:  Expert Opin Ther Pat       Date:  2018-11-23       Impact factor: 6.674

Review 4.  Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Authors:  Nana Zheng; Quansheng Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-05-05

5.  A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia.

Authors:  Peter H Gann; Ryan J Deaton; Erika Enk Rueter; Richard B van Breemen; Larisa Nonn; Virgilia Macias; Misop Han; Viju Ananthanarayanan
Journal:  Nutr Cancer       Date:  2015       Impact factor: 2.900

6.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

7.  Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.

Authors:  Sabina Signoretti; Lucia Di Marcotullio; Andrea Richardson; Sridhar Ramaswamy; Beth Isaac; Montserrat Rue; Franco Monti; Massimo Loda; Michele Pagano
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Estrogen stimulates expression of p21Waf1/Cip1 in mouse uterine luminal epithelium.

Authors:  Ming-Derg Lai; Meei Jyh Jiang; Lih-Yuh C Wing
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

9.  An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.

Authors:  Hongbo Wang; Daqian Sun; Peng Ji; James Mohler; Liang Zhu
Journal:  J Cell Sci       Date:  2008-07-15       Impact factor: 5.285

10.  Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo.

Authors:  Jonathan A Ewald; Joshua A Desotelle; Dawn R Church; Bing Yang; Wei Huang; Timo A Laurila; David F Jarrard
Journal:  Prostate       Date:  2012-08-21       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.